More U.S. women are being prescribed GLP-1 medications after giving birth, particularly those diagnosed with diabetes, according to new research from the USC Schaeffer Center for Health Policy & Economics.
8 hours ago
0
0
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, and in press at The Lancet shows that trevogrumab, which inhibits a protein that ...
Sep 30, 2026
0
85
A genetic vulnerability in clear cell renal cell carcinoma, the most aggressive type of kidney cancer, may lend itself to a combination treatment strategy that causes the cancer cells to self-destruct, according to recent ...
Sep 30, 2026
0
5
Semaglutides, or GLP-1s, can produce substantial weight loss if individuals adhere to their doctor's instructions. But a new study from the University of Georgia suggests patients aren't taking the weight loss medication ...
Sep 30, 2026
0
4
The number of people using GLP-1 treatments like Ozempic and Wegovy for weight loss or chronic conditions has increased rapidly, with more than 1 in 10 U.S. adults currently taking such medications. A new study led by medical ...
Sep 28, 2026
0
11
Caffeine is one of the most widely used performance-enhancing supplements in sports. Despite its established benefits, how long they persist and how physiological responses change over that period remain unclear.
Sep 28, 2026
0
64
New analyses to be presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, show that orforglipron, a daily oral medication for weight loss and type 2 ...
Sep 26, 2026
0
178
Interleukin-6 (IL-6) is a contradictory molecule in immunology. It helps the liver regenerate after injury and protects against infections, yet it also drives chronic inflammation in rheumatic diseases, inflammatory bowel ...
Sep 25, 2026
0
10
Researchers at Wits University, South Africa's National Health Laboratory Service (NHLS) and University Medical Center Utrecht have developed a new way to help people whose HIV viral load increased while they were taking ...
Sep 25, 2026
0
5
A new study by researchers at Lund University in Sweden found that 85% of patients with aura-dominant migraine experienced a reduction in monthly aura days by at least half following treatment with the anti-epileptic drug ...
Sep 25, 2026
0
16
